Cargando…

CKD stage-specific utility of two equations for predicting 1-year risk of ESKD

BACKGROUND: The Kidney Failure Risk Equation (KFRE) and Kaiser Permanente Northwest (KPNW) models have been proposed to predict progression to ESKD among adults with CKD within 2 and 5 years. We evaluated the utility of these equations to predict the 1-year risk of ESKD in a contemporary, ethnically...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Sijie, Parikh, Rishi V., Tan, Thida C., Pravoverov, Leonid, Patel, Jignesh K., Horiuchi, Kate M., Go, Alan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619781/
https://www.ncbi.nlm.nih.gov/pubmed/37910454
http://dx.doi.org/10.1371/journal.pone.0293293
_version_ 1785130062700347392
author Zheng, Sijie
Parikh, Rishi V.
Tan, Thida C.
Pravoverov, Leonid
Patel, Jignesh K.
Horiuchi, Kate M.
Go, Alan S.
author_facet Zheng, Sijie
Parikh, Rishi V.
Tan, Thida C.
Pravoverov, Leonid
Patel, Jignesh K.
Horiuchi, Kate M.
Go, Alan S.
author_sort Zheng, Sijie
collection PubMed
description BACKGROUND: The Kidney Failure Risk Equation (KFRE) and Kaiser Permanente Northwest (KPNW) models have been proposed to predict progression to ESKD among adults with CKD within 2 and 5 years. We evaluated the utility of these equations to predict the 1-year risk of ESKD in a contemporary, ethnically diverse CKD population. METHODS: We conducted a retrospective cohort study of adult members of Kaiser Permanente Northern California (KPNC) with CKD Stages 3–5 from January 2008-September 2015. We ascertained the onset of ESKD through September 2016, and calculated stage-specific estimates of model discrimination and calibration for the KFRE and KPNW equations. RESULTS: We identified 108,091 eligible adults with CKD (98,757 CKD Stage 3; 8,384 CKD Stage 4; and 950 CKD Stage 5 not yet receiving kidney replacement therapy), with mean age of 75 years, 55% women, and 37% being non-white. The overall 1-year risk of ESKD was 0.8% (95%CI: 0.8–0.9%). The KFRE displayed only moderate discrimination for CKD 3 and 5 (c = 0.76) but excellent discrimination for CKD 4 (c = 0.86), with good calibration for CKD 3–4 patients but suboptimal calibration for CKD 5. Calibration by CKD stage was similar to KFRE for the KPNW equation but displayed worse calibration across CKD stages for 1-year ESKD prediction. CONCLUSIONS: In a large, ethnically diverse, community-based CKD 3–5 population, both the KFRE and KPNW equation were suboptimal in accurately predicting the 1-year risk of ESKD within CKD stage 3 and 5, but more accurate for stage 4. Our findings suggest these equations can be used in1-year prediction for CKD 4 patients, but also highlight the need for more personalized, stage-specific equations that predicted various short- and long-term adverse outcomes to better inform overall decision-making.
format Online
Article
Text
id pubmed-10619781
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-106197812023-11-02 CKD stage-specific utility of two equations for predicting 1-year risk of ESKD Zheng, Sijie Parikh, Rishi V. Tan, Thida C. Pravoverov, Leonid Patel, Jignesh K. Horiuchi, Kate M. Go, Alan S. PLoS One Research Article BACKGROUND: The Kidney Failure Risk Equation (KFRE) and Kaiser Permanente Northwest (KPNW) models have been proposed to predict progression to ESKD among adults with CKD within 2 and 5 years. We evaluated the utility of these equations to predict the 1-year risk of ESKD in a contemporary, ethnically diverse CKD population. METHODS: We conducted a retrospective cohort study of adult members of Kaiser Permanente Northern California (KPNC) with CKD Stages 3–5 from January 2008-September 2015. We ascertained the onset of ESKD through September 2016, and calculated stage-specific estimates of model discrimination and calibration for the KFRE and KPNW equations. RESULTS: We identified 108,091 eligible adults with CKD (98,757 CKD Stage 3; 8,384 CKD Stage 4; and 950 CKD Stage 5 not yet receiving kidney replacement therapy), with mean age of 75 years, 55% women, and 37% being non-white. The overall 1-year risk of ESKD was 0.8% (95%CI: 0.8–0.9%). The KFRE displayed only moderate discrimination for CKD 3 and 5 (c = 0.76) but excellent discrimination for CKD 4 (c = 0.86), with good calibration for CKD 3–4 patients but suboptimal calibration for CKD 5. Calibration by CKD stage was similar to KFRE for the KPNW equation but displayed worse calibration across CKD stages for 1-year ESKD prediction. CONCLUSIONS: In a large, ethnically diverse, community-based CKD 3–5 population, both the KFRE and KPNW equation were suboptimal in accurately predicting the 1-year risk of ESKD within CKD stage 3 and 5, but more accurate for stage 4. Our findings suggest these equations can be used in1-year prediction for CKD 4 patients, but also highlight the need for more personalized, stage-specific equations that predicted various short- and long-term adverse outcomes to better inform overall decision-making. Public Library of Science 2023-11-01 /pmc/articles/PMC10619781/ /pubmed/37910454 http://dx.doi.org/10.1371/journal.pone.0293293 Text en © 2023 Zheng et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Zheng, Sijie
Parikh, Rishi V.
Tan, Thida C.
Pravoverov, Leonid
Patel, Jignesh K.
Horiuchi, Kate M.
Go, Alan S.
CKD stage-specific utility of two equations for predicting 1-year risk of ESKD
title CKD stage-specific utility of two equations for predicting 1-year risk of ESKD
title_full CKD stage-specific utility of two equations for predicting 1-year risk of ESKD
title_fullStr CKD stage-specific utility of two equations for predicting 1-year risk of ESKD
title_full_unstemmed CKD stage-specific utility of two equations for predicting 1-year risk of ESKD
title_short CKD stage-specific utility of two equations for predicting 1-year risk of ESKD
title_sort ckd stage-specific utility of two equations for predicting 1-year risk of eskd
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619781/
https://www.ncbi.nlm.nih.gov/pubmed/37910454
http://dx.doi.org/10.1371/journal.pone.0293293
work_keys_str_mv AT zhengsijie ckdstagespecificutilityoftwoequationsforpredicting1yearriskofeskd
AT parikhrishiv ckdstagespecificutilityoftwoequationsforpredicting1yearriskofeskd
AT tanthidac ckdstagespecificutilityoftwoequationsforpredicting1yearriskofeskd
AT pravoverovleonid ckdstagespecificutilityoftwoequationsforpredicting1yearriskofeskd
AT pateljigneshk ckdstagespecificutilityoftwoequationsforpredicting1yearriskofeskd
AT horiuchikatem ckdstagespecificutilityoftwoequationsforpredicting1yearriskofeskd
AT goalans ckdstagespecificutilityoftwoequationsforpredicting1yearriskofeskd